Pateints of β-thalassemia Major With Iron Overload

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Pateints of β-thalassemia Major With Iron Overload trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

CompletedNot Applicable

NCT06468423

Comparison of Deferasirox and Desferoxamine in Patients of β-Thalassemia Major With Iron Overload

This study was planned to compare deferasirox and desferrioxamine in terms of mean serum ferritin levels in patients of β-thalassemia major having Iron overload…

Pakistan142 participantsStarted 2023-01-01

Treatment: Deferasirox (DFX), Deferoxamine (DFO)